Recurrent optic neuromyelitis with endocrinopathies: A new syndrome

Neurology

Volumn 48, Issue 1, 1997, Pages 58-64

  Vernant, J C ^a   Cabre, P ^a   Smadja, D ^a   Merle, H ^a   Caubarrere I ^b   Mikol, J ^c   Poser, C M ^d  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

^b FOCH HOSPITAL   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMENORRHEA; ARTICLE; CLINICAL ARTICLE; DIABETES INSIPIDUS; DISEASE CLASSIFICATION; ENDOCRINE DISEASE; FEMALE; GALACTORRHEA; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HYPOTHYROIDISM; MYELOOPTIC NEUROPATHY; PARAPLEGIA; PRIORITY JOURNAL;

EID: 0031016804     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.1.58     Document Type: Article

References (23)

1. Vernant J, Gessain A, Gout O, et al. Paraparesies spastiques tropicales en Martinique. Presse Méd 1966;15:419-422.
2. Poser C, Vernant J. La sclérose en plaques dans la race noire. Bull Soc Pathol Exot 1993;86:428-432.
3. Lexa F, Grossman R. MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy. AJNR 1994;13:973-982.
4. Gudeman S, Selhorst J, Susac J, et al. Sarcoid optic neuropathy. Neurology 1982;32:597-603.
5. Terunuma H, Konno H, Iizuka H, et al. Sarcoidosis presenting as progressive myelopathy. Clin Neuropathol 1991;7:77-80.
6. Gelwan M, Kellen R, Burde R, et al. Sarcoidosis of the anterior visual pathway: successes and failures. J Neurol Neurosurg Psychiatry 1988;51:1473-1480.
7. Poser C. The epidemiology of multiple sclerosis. Ann Neurol 1994;36(suppl 2):S180-193.
8. Shibasaki H, Kuroda Y, Kuroiwa Y. Clinical studies of multiple sclerosis in Japan: classical multiple sclerosis and Devic's disease. J Neurol Sci 1974;23:215-222.
9. Kuroiwa Y. Neuromyelitis optica. In: Vinken P, Bruyn G, Klawans H, eds. Handbook of clinical neurology, Vol. 47. Amsterdam: Elsevier, 1985:397-408.
10. Kuroiwa Y, Shibasaki H, Tabira T, et al. Clinical picture of MS in Asia. In: Kuroiwa Y, Kurland L, eds. Multiple sclerosis: east and west. Fukuoka. Japan: Kyushu University Press, 1986:31-42.
11. Miller H. Evans M. Prognosis in acute disseminated encephalomyelitis; with a note on neuromyelitis optica. Q J Med 1953; 22:347-379.
12. Poser C. Taxonomy and diagnostic parameters in multiple sclerosis. Ann NY Acad Sci 1984;436:233-245.
13. Leys D, Petit H, Block A, et al. Neuromyélite optique de Devic. Quatre cas. Rev Neurol 1987;143:722-728.
14. Breukelman A, Polman C, de Slegte R, et al. Neuromyelitis optica (Devic's syndrome): not always multiple sclerosis. Clin Neurol Neurosurg 1988;90:357-360.
15. Piccolo G, Franciotta D, Camana C, et al. Devic's neuromyelitis optica: long-term follow-up and serial CSF findings in two cases. J Neurol 1990;237:262-264.
16. Poser C, Roman G, Vernant J. Multiple sclerosis or HTLV-I myelitis? Neurology 1990;40:1020-1022.
17. Fukazawa T, Morikawa F, Mukai M, et al. Anticardiolipin antibodies in Japanese patients with multiple sclerosis. Acta Neurol Scand 1993;88:184-189.
18. Mandler R, Davis L, Jeffery D, et al. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 1993;34:162-168.
19. Kira J, Goto I. Recurrent opticomyelitis associated with anti-DNA antibodies. J Neurol Neurosurg Psychiatry 1994;57: 1124-1125.
20. Fazekas F, Offenbacher H, Schmidt R, et al. MRI of neuromyelitis optica: evidence for a distinct entity. J Neurol Neurosurg Psychiatry 1994;57:1140-1142.
21. Golovkin V, Mikhailenko A, Rakov A. Pathogenetic role of prolactinemia in multiple sclerosis. Sov Med 1991;10:15-17.
22. Kira J, Harada M, Yamaguchi Y, et al. Hyperprolactinemia in multiple sclerosis. J Neurol Sci 1991;102:61-66.
23. Reder A, Lowy T. Serum prolactin levels in active multiple sclerosis and during cyclosporine treatment. J Neurol Sci 1993;117:192-196.